Ryan J. Hansen - Concepedia

Author

Ryan J. Hansen

Colorado State University

Also Known As

Hansen, Ryan J., RYAN J HANSEN, RYAN J. HANSEN, Ryan Hansen, Ryan J Hansen, Ryan J. Hansen

139

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Colorado State University Eli Lilly (United States)University of Colorado Denver University at Buffalo, State University of New York University of Oregon

About

Ryan J. Hansen is an author at Colorado State University specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.1K
2	Allergy	4	4	228
3	Engineering	2	2	197
4	Health Sciences	2	2	110
5	Natural Sciences	2	2	202

Ryan J. Hansen

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
STAT3-Mediated Autophagy Dependence Identifies Subtypes of Breast Cancer Where Autophagy Inhibition Can Be Efficacious Paola Maycotte, Christy M. Gearheart, Rebecca Barnard, Cancer Research MitophagyBreast OncologyImmunologyCell DeathCancer Biology	2014	184
Development of Selective Colorimetric Probes for Hydrogen Sulfide Based on Nucleophilic Aromatic Substitution Leticia Montoya, Taylor F. Pearce, Ryan J. Hansen, The Journal of Organic Chemistry Bioorganic ChemistryThiol ReactivityEngineeringOrganic ChemistryChemistry	2013	177
Intravenous Immunoglobulin Mediates an Increase in Anti-Platelet Antibody Clearance via the FcRn Receptor Ryan J. Hansen, Joseph P. Balthasar Thrombosis and Haemostasis Intravenous ImmunoglobulinImmunologyImmunodominanceImmunologic MechanismImmunotherapy	2002	159
Lipid-lowering effect of berberine in human subjects and rats Yueshan Hu, Erik A. Ehli, Julie M. Kittelsrud, Phytomedicine Pharmacological StudyMedicinePhysiologyHerb-drug InteractionLipid-lowering Effect	2012	133
Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia Ryan J. Hansen, Joseph P. Balthasar Blood	2002	124
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC Triparna Sen, Carminia Maria Della Corte, Snezana Milutinovic, Journal of Thoracic Oncology Immune MicroenvironmentNovel TherapyMedicineImmunologyCell Death	2019	118
Properties of a general PK/PD model of antibody-ligand interactions for therapeutic antibodies that bind to soluble endogenous targets Jasmine Davda, Ryan J. Hansen mAbs Antibody-ligand InteractionsImmunocytochemical TechniqueTherapeutic AntibodiesMedicineBioanalysis	2010	88
Pharmacokinetics of sustained-release analgesics in mice. Lon V. Kendall, Ryan J. Hansen, Kathryn Dorsey, PubMed Sr FormulationsHealth SciencesAnaesthetic AgentPharmacological StudyPain Medicine	2014	73
Pharmacokinetic/Pharmacodynamic Modeling of the Effects of Intravenous Immunoglobulin on the Disposition of Antiplatelet Antibodies in a Rat Model of Immune Thrombocytopenia Ryan J. Hansen, Joseph P. Balthasar Journal of Pharmaceutical Sciences ThrombopoiesisThrombosisAntiplatelet AntibodiesAutoimmune DiseaseBlood Platelet	2003	71
Substituent Effects in CH Hydrogen Bond Interactions: Linear Free Energy Relationships and Influence of Anions Blakely W. Tresca, Ryan J. Hansen, Calvin V. Chau, Journal of the American Chemical Society	2015	68

Page 1